Status:
COMPLETED
Constraint-Induced Movement Therapy in a Pediatric Oncology Population
Lead Sponsor:
St. Jude Children's Research Hospital
Conditions:
Hemiplegia
Brain Tumor
Eligibility:
All Genders
2-12 years
Phase:
NA
Brief Summary
Hemiplegia (weakness or poor muscle function on one side of the body) is a neurological impairment which can occur in children as a result of a brain tumor or related treatment. This impairment can ne...
Detailed Description
Constraint Induced Therapy (CI Therapy) is based on the theory of "learned non-use." Following an event that impacts the brain (stroke, brain injury etc.), the messages from the brain to the arm and t...
Eligibility Criteria
Inclusion
- Diagnosed hemiplegia of an upper extremity as documented by physician or rehabilitation clinician in the medical record
- Diagnosis of brain tumor
- English speaking
- Participant has demonstrated the ability in the past to move the elbow \>70 degrees and has some purposeful movement in the hand (ability to initiate a gross grasp).
- Parent/legal guardian is willing to give consent to participate in the study.
- Child is willing to give assent in the study if seven years old or older.
Exclusion
- Severe hemiplegia and resulting active range of motion deficits at the affected upper extremity as defined by the following:
- \< 30 degrees active shoulder flexion or abduction
- Inability to initiate active elbow flexion or extension.
- Inability to initiate movements at the of wrist, finger or thumb
- Uncontrolled seizures that interfere with daily activities, as this would interfere with the participant's ability to fully participate in the CI Therapy program.
- Pain that significantly interferes with the participant's ability to fully participate in the intensive therapy program. This includes pain related to subluxation of the shoulder, as measured by a pain rating of 5/10 or greater on the FACES or Numeric Pain Scale.
- Currently receiving oral or intravenous chemotherapy or radiation therapy.
- Inability or unwillingness of legal guardian to give written informed consent.
- Child is unwilling to give assent if seven years old or older.
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01447810
Start Date
October 1 2011
End Date
December 1 2013
Last Update
January 14 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Jude Children's Research Hospital
Memphis, Tennessee, United States, 38105